These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33323378)

  • 21. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features.
    Islam F; Gopalan V; Law S; Tang JC; Lam AK
    Hum Pathol; 2019 May; 87():1-10. PubMed ID: 30794892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.
    Du W; Gao A; Herman JG; Wang L; Zhang L; Jiao S; Guo M
    Cancer Sci; 2021 Jul; 112(7):2870-2883. PubMed ID: 33931924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer.
    Zhu Y; Lam AKY; Shum DKY; Cui D; Zhang J; Yan DD; Li B; Xu WW; Lee NPY; Chan KT; Law S; Tsao SW; Cheung ALM
    Theranostics; 2021; 11(6):2722-2741. PubMed ID: 33456569
    [No Abstract]   [Full Text] [Related]  

  • 27. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
    Gen Y; Yasui K; Nishikawa T; Yoshikawa T
    Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
    Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
    Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
    Shinno N; Kimura H; Sada R; Takiguchi S; Mori M; Fumoto K; Doki Y; Kikuchi A
    Oncogene; 2018 Jun; 37(26):3471-3484. PubMed ID: 29563607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways.
    Zhu J; Qiu X; Jin X; Nie X; Ou S; Wu G; Shen J; Zhang R
    Cell Oncol (Dordr); 2024 Oct; 47(5):1927-1942. PubMed ID: 39141315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
    Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
    BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
    Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
    Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic variant associated with survival of esophageal squamous cell carcinoma.
    Tian J; Lu Z; Niu S; Zhang S; Ying P; Wang L; Zhang M; Cai Y; Dong T; Zhu Y; Zhong R; Wang Z; Chang J; Miao X
    Clin Transl Med; 2021 Jun; 11(6):e485. PubMed ID: 34185429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis.
    Zhang Y; Zhang Y; Ai B; Gong J; Li Y; Yu S; Cai X; Zhang L
    Oncogene; 2022 Feb; 41(6):782-796. PubMed ID: 34853466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling.
    Zhu DS; Dong JY; Xu YY; Zhang XT; Fu SB; Liu W
    Med Sci Monit; 2020 Aug; 26():e927106. PubMed ID: 32804918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
    Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.